Literature DB >> 11245326

Antibiotic susceptibilities among recent clinical isolates of Haemophilus influenzae and Moraxella catarrhalis from fifteen countries.

S I Bandak1, M R Turnak, B S Allen, L D Bolzon, D A Preston, S K Bouchillon, D J Hoban.   

Abstract

Between July 1998 and July 1999, 3,060 Haemophilus influenzae and 1,486 Moraxella catarrhalis strains were isolated in 31 centers in 15 countries in order to determine their antimicrobial susceptibilities and the presence of beta-lactamase production in Haemophilus influenzae. Overall 17.1% of the Haemophilus influenzae isolates were beta-lactamase positive, while more than 95% were susceptible to amoxicillin/clavulanate, cefaclor, loracarbef, cefuroxime, azithromycin and ciprofloxacin. Eleven (0.3%) isolates were beta-lactamase positive and ampicillin resistant and 7 (0.2%) isolates were ciprofloxacin resistant. The minimum inhibitory concentrations for 90% of the isolates tested were lowest for ciprofloxacin (0.03) and highest for cefprozil (8) against Moraxella catarrhalis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11245326     DOI: 10.1007/pl00011235

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  8 in total

1.  Characterization of the Moraxella catarrhalis opa-like protein, OlpA, reveals a phylogenetically conserved family of outer membrane proteins.

Authors:  Michael J Brooks; Cassie A Laurence; Eric J Hansen; Scott D Gray-Owen
Journal:  J Bacteriol       Date:  2006-10-13       Impact factor: 3.490

2.  Specific immune responses and enhancement of murine pulmonary clearance of Moraxella catarrhalis by intranasal immunization with a detoxified lipooligosaccharide conjugate vaccine.

Authors:  Xinan Jiao; Takashi Hirano; Yingchun Hou; Xin-Xing Gu
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

3.  Roles of 3-deoxy-D-manno-2-octulosonic acid transferase from Moraxella catarrhalis in lipooligosaccharide biosynthesis and virulence.

Authors:  Daxin Peng; Biswa P Choudhury; Ronald S Petralia; Russell W Carlson; Xin-Xing Gu
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

4.  Moraxella catarrhalis bacterium without endotoxin, a potential vaccine candidate.

Authors:  Daxin Peng; Wenzhou Hong; Biswa P Choudhury; Russell W Carlson; Xin-Xing Gu
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

Review 5.  Amoxicillin/clavulanic acid: a review of its use in the management of paediatric patients with acute otitis media.

Authors:  Jane Easton; Stuart Noble; Caroline M Perry
Journal:  Drugs       Date:  2003       Impact factor: 9.546

6.  Identification of a 3-deoxy-D-manno-octulosonic acid biosynthetic operon in Moraxella catarrhalis and analysis of a KdsA-deficient isogenic mutant.

Authors:  Nicole R Luke; Simon Allen; Bradford W Gibson; Anthony A Campagnari
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

7.  Prevalence and resistance pattern of Moraxella catarrhalis in community-acquired lower respiratory tract infections.

Authors:  Safia Bader Uddin Shaikh; Zafar Ahmed; Syed Ali Arsalan; Sana Shafiq
Journal:  Infect Drug Resist       Date:  2015-07-31       Impact factor: 4.003

8.  The immunogenicity of the liposome-associated outer membrane proteins (OMPs) of Moraxella catarrhalis.

Authors:  Daria Augustyniak; Józef Mleczko; Jan Gutowicz
Journal:  Cell Mol Biol Lett       Date:  2009-10-22       Impact factor: 5.787

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.